Influence of stereochemistry on the activity of rapadocin, an isoform-specific inhibitor of the nucleoside transporter ENT1. Issue 34 (2nd August 2021)

• Record Type: Journal Article
• Authors: Wang, Yuefan; Peng, Hanjing; Guo, Zufeng; Ullman, Brett R.; Yamamoto, Kana; Hong, Sam Y.; Liu, Jun O.
• Is Part Of: Chemical science. Volume 12:Issue 34(2021)
• Page Start: 11484
• Page End: 11489
• Publication Date: 2021-08-02
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/d1sc02295d
• Languages: English
• ISSNs: 2041-6520

Abstract

Abstract : Rapadocin is a novel rapamycin-inspired polyketide–tetrapeptide hybrid macrocycle that possesses highly potent and isoform-specific inhibitory activity against the human equilibrative nucleoside transporter 1 (hENT1). Abstract : Rapadocin is a novel rapamycin-inspired polyketide–tetrapeptide hybrid macrocycle that possesses highly potent and isoform-specific inhibitory activity against the human equilibrative nucleoside transporter 1 (hENT1). Rapadocin contains an epimerizable chiral center in phenylglycine and an olefin group, and can thus exist as a mixture of four stereoisomers. Herein, we report the first total synthesis of the four stereoisomers of rapadocin using two different synthetic strategies and the assignment of their structures. The inhibitory activity of each of the four synthetic isomers on both hENT1 and hENT2 was determined. It was found that the stereochemistry of phenylglycine played a more dominant role than the configuration of the olefin in the activity of rapadocin. These findings will guide the future design and development of rapadocin analogs as new modulators of adenosine signaling.